Aoyagi, T., & 		Kuroda, I.
(2022).
 Castration-Synchronized Upfront Docetaxel for metastatic Hormone Sensitive Prostate Cancer considering Epithelial to Mesenchymal Transition.
<em>Medical Research Archives, 10</em>(10).
doi:10.18103/mra.v10i10.3235